Patents by Inventor Raymond George Hill

Raymond George Hill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of a COX-2 inhibitor and a NK-1 receptor antagonist for treating inflammation
    Publication number: 20040097573
    Abstract: The present invention provides the use of a COX-2 inhibitior and an NK-1 receptor antagonist for the treatment or prevention of inflammatory disorders.
    Type: Application
    Filed: July 7, 2003
    Publication date: May 20, 2004
    Inventors: Susan Boyce, Raymond George Hill, Nadia Melanie Rupniak
  • Benzimidazolinyl piperidines as CGRP ligands
    Patent number: 6552043
    Abstract: The present invention relates to benzimidazolinylpiperidine derivatives useful as ligands for CGRP (Calcitonin Gene-Related Peptide) receptors, their use in therapy, pharmaceutical compositions comprising them and methods of treatment using them.
    Type: Grant
    Filed: May 30, 2001
    Date of Patent: April 22, 2003
    Assignees: Merck Sharpe & Dohme Ltd., Merck & Co, Inc.
    Inventors: Arthur A. Patchett, Raymond George Hill, Lihu Yang
  • Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception
    Patent number: 6180624
    Abstract: This invention relates to methods and compositions for treating pain and nociception in a patient by administering a combination of a morpholine or thiomorpholine tachykinin antagonist and an opioid analgesic.
    Type: Grant
    Filed: February 25, 1999
    Date of Patent: January 30, 2001
    Assignee: Merck Sharp & Dohme Limited
    Inventor: Raymond George Hill
  • Analgesic use of triazolo-pyridazine derivatives
    Patent number: 6063783
    Abstract: A class of substituted 7,8-ring fused 1,2,4-triazolo[4,3-b]pyridazine derivatives as shown in Formula I, possessing an optionally substituted cycloalkyl, phenyl or heteroaryl substituent at the 3-position and a substituted alkoxy moiety at the 6-position, are selective ligands for GABA.sub.A receptors, in particular having high affinity for the .alpha.2 and/or .alpha.3 subunit thereof, and are accordingly of benefit in the treatment and/or prevention of pain.
    Type: Grant
    Filed: December 10, 1998
    Date of Patent: May 16, 2000
    Assignee: Merck Sharp & Dohme Ltd.
    Inventors: Jose Luis Castro Pineiro, Raymond George Hill
  • Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception
    Patent number: 5880132
    Abstract: This invention relates to methods and compositions for treating pain and nociception in a patient by administering a combination of a piperidine tachykinin antagonist and an opioid analgesic.
    Type: Grant
    Filed: June 20, 1997
    Date of Patent: March 9, 1999
    Assignee: Merck Sharp & Dohme Limited
    Inventor: Raymond George Hill